Tuesday, November 03 2026

Listed pharma companies’ profits rise 11pc in 1QFY27
Pakistan’s listed pharmaceutical sector recorded profits of Rs11.6 billion in the first quarter of FY27, up 11 percent year-on-year (YoY) and 54 percent quarter-on-quarter (QoQ), mainly driven by higher sales and improved gross margins, according to a report by Topline Research. Despite the earnings growth, the sector’s market capitalisation declined 24 percent YoY and 13 percent QoQ to Rs505.2 billion. The sector’s net sales increased 5 percent YoY and 11 percent QoQ to Rs98.8 billion in 1QFY27. Topline Research attributed the increase mainly to a combination of price and volume growth.
Related news categories: business economic-indicators pharma psx stock-exchanges

Friday, October 30 2026

Haleon Pakistan starts local manufacturing of Panadol 500mg tablets in Sindh
Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has commenced manufacturing Panadol 500mg tablets at its Jamshoro facility, marking a shift towards in-house production of the popular pain relief medicine. The company, which is primarily engaged in the manufacturing, marketing, and sale of consumer healthcare and over-the-counter (OTC) health products, disclosed the development in a notice to the Pakistan Stock Exchange (PSX) on Friday.
Related news categories: business economic-indicators pharma psx stock-exchanges
Related symbols: haleon (news stock)

Monday, October 19 2026

Citi Pharma receives CCP nod to acquire Pakheim International
Citi Pharma Limited (CPHL) has received regulatory approval for its proposed acquisition of Pakheim International Pharma (Private) Limited. The company disclosed the development in a filing to the Pakistan Stock Exchange on Monday. “CPHL hereby informs its shareholders and the general public that the company has received the order dated October 9, 2026, passed by the Competition Commission of Pakistan (CCP) in Case No. 1614/Merger-CCP/2026, authorising the proposed acquisition of 100% shareholding of Pakheim International Pharma (Private) Limited under Section 31(1)(d)(i) of the Competition Act, 2010,” read the notice.
Related news categories: business economic-indicators pharma psx stock-exchanges
Related symbols: cphl (news stock)